Medicare Enrolled
Dr. Amir Faridi, M.D.
Hematology & Oncology · Denison, TX
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Consulting-driven
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Faridi from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Faridi? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Faridi
Dr. Amir Faridi is a hematology & oncology in Denison, TX, with 19 years in practice. Based on federal Medicare data, Dr. Faridi performed 137,445 Medicare services across 5,514 unique beneficiaries.
Between the years covered by Open Payments, Dr. Faridi received a total of $56,926 from 60 pharmaceutical and/or device companies across 208 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Faridi is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice▲ Top 3% volume in TX$ $56,926 industry payments
Medicare Practice Summary
Medicare Utilization ↗137,445
Medicare services
Top 3% in TX for hematology & oncology
5,514
Unique beneficiaries
$12
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~7,234 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Feraheme) | 30,600 | $0 | $5 |
| Iron sucrose injection (Venofer) | 14,100 | $0 | $2 |
| Oxaliplatin chemotherapy injection | 14,100 | $0 | $33 |
| Pembrolizumab injection (Keytruda) | 13,200 | $44 | $137 |
| Nivolumab injection (Opdivo) | 8,480 | $24 | $77 |
| Darbepoetin injection (Aranesp) for anemia | 7,625 | $2 | $20 |
| Contrast dye for imaging (iodine-based) | 6,680 | $0 | $3 |
| Paclitaxel chemotherapy injection | 6,620 | $0 | $8 |
| Anti-nausea injection (fosaprepitant) | 3,900 | $0 | $5 |
| Denosumab injection (Prolia/Xgeva) | 3,360 | $19 | $67 |
| Injection, docetaxel, 1 mg | 2,878 | $1 | $66 |
| Injection, bevacizumab-bvzr, biosimilar, (zirabev), 10 mg | 2,345 | $22 | $155 |
| Dexamethasone injection (steroid) | 2,195 | $0 | $1 |
| Complete blood count (CBC) with differential | 1,932 | $8 | $36 |
| Blood draw (venipuncture) | 1,778 | $8 | $20 |
| Injection, atropine sulfate, 0.01 mg | 1,520 | $0 | $1 |
| Comprehensive metabolic blood panel | 1,519 | $10 | $64 |
| Injection, bortezomib, 0.1 mg | 1,155 | $4 | $116 |
| Injection, leucovorin calcium, per 50 mg | 1,149 | $3 | $25 |
| Immune globulin infusion (Octagam) | 1,140 | $33 | $233 |
| Injection, fluorouracil, 500 mg | 879 | $2 | $13 |
| Injection, granisetron hydrochloride, 100 mcg | 850 | $0 | $24 |
| Office visit, established patient (30-39 min) | 748 | $88 | $368 |
| Office visit, established patient (20-29 min) | 695 | $62 | $250 |
| Injection, irinotecan, 20 mg | 531 | $2 | $210 |
| Anti-nausea injection (Aloxi/palonosetron) | 500 | $1 | $114 |
| Injection, etoposide, 10 mg | 470 | $1 | $13 |
| Administration of chemotherapy into vein, 1 hour or less | 398 | $97 | $707 |
| Injection, carboplatin, 50 mg | 382 | $2 | $300 |
| Ferritin level test (iron stores) | 334 | $13 | $60 |
| Iron level test | 328 | $6 | $27 |
| Iron binding capacity test | 328 | $8 | $35 |
| Injection of additional new drug or substance into vein | 279 | $11 | $108 |
| Injection, zoledronic acid, 1 mg | 272 | $6 | $431 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 239 | $22 | $157 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 223 | $46 | $313 |
| Lactate dehydrogenase (enzyme) level | 197 | $6 | $31 |
| Administration of additional new drug or substance into vein, 1 hour or less | 168 | $49 | $344 |
| Injection, cisplatin, powder or solution, 10 mg | 168 | $2 | $94 |
| Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg | 162 | $3 | $373 |
| Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 157 | $54 | $211 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 156 | $91 | $657 |
| Urinalysis, manual | 153 | $3 | $15 |
| New patient office visit (45-59 min) | 148 | $114 | $565 |
| Enhancing oncology model (eom) monthly enhanced oncology services (meos) payment for eom enhanced services | 146 | $74 | $70 |
| Administration of chemotherapy into vein, each additional hour | 140 | $21 | $161 |
| Nuclear medicine study from skull base to mid-thigh with ct scan | 139 | $1,108 | $4,802 |
| Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session | 136 | $272 | $2,762 |
| Drug injection, under skin or into muscle | 134 | $10 | $96 |
| Carcinoembryonic antigen (cea) protein level | 127 | $19 | $99 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 121 | $131 | $3,675 |
| Injection, fosnetupitant 235 mg and palonosetron 0.25 mg | 119 | $336 | $1,722 |
| Injection, magnesium sulfate, per 500 mg | 106 | $1 | $6 |
| Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion | 86 | $15 | $94 |
| Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l | 84 | $124 | $500 |
| Magnesium level test | 81 | $7 | $29 |
| Ct scan of chest with contrast | 80 | $57 | $821 |
| Injection, diphenhydramine hcl, up to 50 mg | 80 | $1 | $7 |
| Administration of additional new drug or substance into vein using push technique | 74 | $42 | $289 |
| PSA test (prostate cancer screening) | 70 | $18 | $94 |
| Irrigation of implanted venous access drug delivery device | 66 | $18 | $114 |
| Microscopic examination for white blood cells with manual cell count | 63 | $4 | $22 |
| Complete blood count (CBC), automated | 63 | $6 | $34 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 57 | $26 | $145 |
| Infusion, normal saline solution , 1000 cc | 56 | $2 | $19 |
| CT scan of abdomen and pelvis with contrast | 48 | $168 | $1,067 |
| Unclassified drugs | 43 | $1 | $8 |
| Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | 36 | $15 | $100 |
| Radiation treatment delivery,3 or more separate treatment areas, custom blocking, tangential ports, wedges, rotational beam, compensators, electron beam; 11-19 mev | 34 | $178 | $700 |
| Blood creatinine level | 27 | $5 | $31 |
| Nuclear medicine study whole body with ct scan | 26 | $1,107 | $4,929 |
| Radiation treatment delivery,3 or more separate treatment areas, custom blocking, tangential ports, wedges, rotational beam, compensators, electron beam; 6-10 mev | 25 | $177 | $700 |
| Stool analysis for blood to screen for colon tumors | 24 | $4 | $24 |
| Red blood count automated, with additional calculations | 21 | $5 | $26 |
| Uric acid level test | 20 | $4 | $25 |
| Initial hospital admission, moderate complexity | 20 | $100 | $470 |
| Infusion into a vein for hydration, each additional hour | 18 | $9 | $75 |
| Red blood count, automated test | 17 | $4 | $23 |
| Drawing of blood for a medical problem | 17 | $57 | $264 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
23.6% high complexity
69.4% medium
7.0% routine
Industry Payment Transparency
Open Payments through 2024 ↗$56,926
Total received (2018-2024)
Avg $8,132/year across 7 years
Top 11% in TX for hematology & oncology
60
Companies
208
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$41,296 (72.5%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$12,955 (22.8%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$2,392 (4.2%)
Other
Charitable contributions, space rental, and other categories
$283 (0.5%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$612
2023$7,836
2022$8,093
2021$8,365
2020$5,171
2019$12,738
2018$14,112
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Bayer HealthCare Pharmaceuticals Inc.
$10,591
Gilead Sciences, Inc.
$6,370
AstraZeneca Pharmaceuticals LP
$4,776
PFIZER INC.
$4,723
Deciphera Pharmaceuticals Inc.
$4,531
Kyowa Kirin, Inc.
$3,204
Karyopharm Therapeutics Inc.
$2,252
Novartis Pharmaceuticals Corporation
$2,122
Genentech USA, Inc.
$1,949
CTI BioPharma Corp.
$1,749
Seattle Genetics, Inc.
$1,590
Janssen Biotech, Inc.
$1,542
Epizyme, Inc.,
$1,330
Bayer Healthcare Pharmaceuticals Inc.
$1,323
ARRAY BIOPHARMA INC
$1,260
Aveo Pharmaceuticals, Inc.
$1,069
Janssen Scientific Affairs, LLC
$1,010
E.R. Squibb & Sons, L.L.C.
$985
Incyte Corporation
$819
EMD Serono, Inc.
$527
Heron Therapeutics, Inc.
$513
Astellas Pharma US Inc
$513
NOVARTIS PHARMACEUTICALS CORPORATION
$283
Athenex Pharmaceutical Division, LLC
$175
Inari Medical, Inc.
$150
Merck Sharp & Dohme Corporation
$138
GlaxoSmithKline, LLC.
$134
Seagen Inc.
$124
Janssen Products, LP
$100
Exelixis Inc.
$84
Tempus AI, Inc
$77
Amgen Inc.
$68
GENZYME CORPORATION
$59
BeiGene USA, Inc.
$55
SERVIER PHARMACEUTICALS LLC
$53
Ipsen Biopharmaceuticals, Inc
$47
Agios Pharmaceuticals, Inc.
$42
Daiichi Sankyo Inc.
$41
ABBVIE INC.
$39
Lilly USA, LLC
$35
Dova Pharmaceuticals
$35
Takeda Pharmaceuticals U.S.A., Inc.
$35
Merck Sharp & Dohme LLC
$32
Medtronic, Inc.
$32
PharmaEssentia USA Corporation
$29
Rigel Pharmaceuticals, Inc.
$28
Blueprint Medicines Corporation
$26
Celgene Corporation
$26
G1 Therapeutics, Inc.
$25
Acrotech Biopharma LLC
$24
Pharmacyclics LLC, an AbbVie Company
$22
Taiho Oncology, Inc.
$21
Regeneron Healthcare Solutions, Inc.
$21
Boehringer Ingelheim Pharmaceuticals, Inc.
$20
Verastem, Inc.
$20
Eisai Inc.
$18
Pharmacyclics LLC, An AbbVie Company
$16
Stemline Therapeutics Inc.
$15
Puma Biotechnology, Inc.
$14
Medtronic USA, Inc.
$12
Top 3 companies account for 38.2% of total payments
Associated products mentioned in payments ›
ADCETRIS · ALUNBRIG · AYVAKIT · Aliqopa · Avastin · BELEODAQ · BESREMI · BRAFTOVI · BRUKINSA · Bavencio · CABOMETYX · CALQUENCE · CINVANTI · COSELA · Cabometyx · Copiktra · DARZALEX · Doptelet · ELIQUIS · EPKINLY · Enhertu · Erleada · FLOWTRIEVER CATHETER · FOTIVDA · FRUZAQLA · GILOTRIF · IBRANCE · IMBRUVICA · IMFINZI · INLYTA · Imbruvica · JAKAFI · KEYTRUDA · KISQALI · Kyprolis · LIBTAYO · LUMAKRAS · Lenvima · Lonsurf · MONJUVI · Nerlynx · Neulasta · Nexavar · Nubeqa · OPDIVO · OSTEOCOOL RF ABLATION · OSTEOCOOL RF ABLATION SYSTEM · Onivyde · Orserdu · PADCEV · PEMAZYRE · POTELIGEO · PROMACTA · Perjeta · Pomalyst · QINLOCK · REBLOZYL · Rezlidhia · S · SARCLISA · SCEMBLIX · SUSTOL · Stivarga · TAGRISSO · TALZENNA · TASIGNA · TAZVERIK · TECENTRIQ · TIBSOVO · Tepmetko · Trodelvy · VENCLEXTA · VERZENIO · Vitrakvi · Vonjo · XPOVIO · XTANDI · Xofigo · Xospata · ZEJULA · ZYTIGA · Zydelig
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (72%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers.
Equivalent to $41 per 100 Medicare services performed
Geographic Context
Hematology & Oncologys within 10 mi
3
Per 100K population
2.1
County median income
$70,455
Nearest hospital
TEXOMA MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Faridi is a mixed practice specialist, with above-average Medicare volume (top 3% in TX), and high industry engagement (consulting-driven, top 11%), with 19 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Faridi experienced with iron infusion (feraheme)?
Based on Medicare claims data, Dr. Faridi performed 30,600 iron infusion (feraheme) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Faridi receive payments from pharmaceutical companies?
Yes. Dr. Faridi received a total of $56,926 from 60 companies across 208 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Faridi's costs compare to other hematology & oncologys in Denison?
Dr. Faridi's average Medicare payment per service is $12. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Faridi) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncologys in Denison
Browse hematology & oncologys in Denison ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncologys in TX
Hematology & Oncologys ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncologys in TX
Which TX hematology & oncologys receive the most from drug and device companies.
By company
Bayer HealthCare Pharmaceuticals Inc. Payments to Doctors
See all physicians who received payments from Bayer HealthCare Pharmaceuticals Inc..
By company
Gilead Sciences, Inc. Payments to Doctors
See all physicians who received payments from Gilead Sciences, Inc..
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology